在甲状腺癌中,基因素氨酸脱甲基酶 (KDM) 的性别特异表达
Leila Shobab1, Hui Zheng2, Kirk Jensen3
1Department of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.
Cancers
|April 13, 2024
概括
甲状腺癌表现出性别特异的分子差异. 甲状腺瘤中的性别偏差基因表达和基因素脱甲基酶 (KDMs) 改变可能解释了为什么女性更常患甲状腺癌.
科学领域:
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 与男性相比,女性的甲状腺癌发病率明显高.
- 了解这些性别差异的分子基础至关重要.
研究的目的:
- 为了研究甲状腺癌的性别特异性分子变化.
- 描述正常甲状腺组织和瘤中性别偏差基因的表达.
主要方法:
- 利用癌症基因组图谱 (TCGA) 数据的发明路径分析来识别性别偏见的基因网络.
- 进行实时PCR和免疫染以确认基因素氨酸脱甲基酶 (KDMs) 的表达.
主要成果:
- 鉴定出44个性别偏差基因在男性上调,28个在正常甲状腺中的女性.
- 发现51%的性别偏差基因在癌症组织中表现出改变.
- 观察到KDMs (KDM5C,KDM5D,KDM6A) 的性别特异性表达模式,在瘤中改变了细胞内定位.
结论:
- 正常的甲状腺表现出一个独特的性别特异性的分子特征.
- 甲状腺癌的发展涉及性别偏差基因的差异表达.
- 性别特定的KDM表达和癌症中变化的局部化可能导致甲状腺瘤发生的性别差异.
相关概念视频
Histone Modification
13.3K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.3K
Epigenetic Regulation
31.1K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
31.1K
Inheritance of Chromatin Structures
6.2K
Epigenetics is the study of inherited changes in a cell's phenotype without changing the DNA sequences. It provides a form of memory for the differential gene expression pattern to maintain cell lineage, position-effect variegation, dosage compensation, and maintenance of chromatin structures such as telomeres and centromeres. For example, the structure and location of the centromere on chromosomes are epigenetically inherited. Its functionality is not dictated or ensured by the underlying...
6.2K
Spreading of Chromatin Modifications
8.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.3K
lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Histone Variants at the Centromere
4.3K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.3K


